Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism

37Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Background: Avenanthramides (AVN) are a relatively unstudied family of phytochemicals that could be novel chemotherapeutics. These compounds, found in oats, are non-toxic to healthy cells and have been shown to reduce viability of human colon and liver cancers in vitro. However, these studies do not elucidate a molecular mechanism for individual AVN. In this study we aim to see the effects of AVN on MDA-MB-231 breast cancer cells. Methods: An MTT assay was used to determine cell viability. Staining and analysis with a flow cytometer was used to identify cell cycle progression and apoptosis. FloJo software was used to analyze the cytometric data. In all experiments, statistical significance was determined by a two-tailed t test. Results: This study demonstrates that AVN-A, B, and C individually reduce viability in the MDA-MB-231 breast cancer cell line. AVN-C has the most potent decrease in tumor cell viability, decreasing viable cells to below 25% at 400μM when compared to control after 96h. We demonstrate that treatment with AVN-C causes DNA fragmentation and accumulation of over 90% of cells into a sub G1 cell cycle population. Further, we conclude that AVN-C treated cells activate apoptosis because 97% of treated cells stain positive for annexin V while 91% have caspase-3/7 activity, a late marker of apoptosis. Conclusions: Breast cancer cells treated with AVN-C have a decrease in cell viability, an increase in the sub G1 population, and stain positive for both annexin V and caspase activity, indicating that AVN-C induces apoptosis in breast cancer cells. These compounds may be able to act as chemotherapeutics as demonstrated through future in vivo studies.

References Powered by Scopus

Hallmarks of cancer: The next generation

51847Citations
N/AReaders
Get full text

The hallmarks of cancer

24266Citations
N/AReaders
Get full text

Natural polyphenols for prevention and treatment of cancer

576Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Potential phytocompounds for developing breast cancer therapeutics: Nature's healing touch

97Citations
N/AReaders
Get full text

Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases

69Citations
N/AReaders
Get full text

Avenanthramide A Induces Cellular Senescence via miR-129-3p/Pirh2/p53 Signaling Pathway To Suppress Colon Cancer Growth

54Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hastings, J., & Kenealey, J. (2017). Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism. Cancer Cell International, 17(1). https://doi.org/10.1186/s12935-017-0464-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

62%

Researcher 5

24%

Professor / Associate Prof. 2

10%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 7

37%

Agricultural and Biological Sciences 5

26%

Medicine and Dentistry 4

21%

Pharmacology, Toxicology and Pharmaceut... 3

16%

Save time finding and organizing research with Mendeley

Sign up for free